Because the FDA does not require any understanding of the mechanism by which a drug acts, it could be tempting to move into clinical trials without this knowledge. However, this may set the stage ...
The defects in molecular and cellular processes that constitute the triggers of specific pathologies are referred to as mechanisms of disease. Research in this area is vital for designing ...